Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P120021/S028

AmplatzerTM PFO Occluder; AmplatzerTM Talisman PFO Occluder

ABBOTT MEDICAL · Decision date May 28, 2026

FDA DECISIONP120021/S028

What did the FDA decide?

FDA records P120021/S028 as a supplement to PMA P120021, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated May 28, 2026.

FDA approval order statement

adding an alternate polyethylene terephthalate (PET) yarn supplier
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
May 28, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P120021/S028
Regulatory pathway
PMA supplement
Product code
MLV
Decision code
OK30
Decision date
May 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Transcatheter septal occluder.

Product code
MLV
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P120021/S027 · Related supplement

    Amplatzer PFO Occluder; Amplatzer Talisman PFO Occluder

  2. P120021/S028 received

    Application receipt date recorded by FDA.

  3. P120021/S028 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P120021. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P120021

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementOct 23, 2025FDA

Explore the linked device profile

Other records with product code MLV

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
177 County Rd. B E., St. Paul, MN, 55117

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records